What is the current Price Target for the Biohaven Pharmaceutical Holding Company Ltd. stock?

The average Biohaven Pharmaceutical Holding Company Ltd. target price is $62.20. This is 202.68% higher than the current stock price. The highest price target is 269.83%, the lowest is 162.77%. 15 Analysts have issued a price target Biohaven Pharmaceutical Holding Company Ltd. 2026 .

What's going on with the Biohaven Pharmaceutical Holding Company Ltd. stock today?

The performance of Biohaven Pharmaceutical Holding Company Ltd. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Biohaven Pharmaceutical Holding Company Ltd. Forecast, price target & analysts

Q: How high will the Biohaven Pharmaceutical Holding Company Ltd. stock rise?

No reliable answer can be given as to how high the Biohaven Pharmaceutical Holding Company Ltd. stock will rise. The performance of stocks, including the Biohaven Pharmaceutical Holding Company Ltd. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

Q: Why did the Biohaven Pharmaceutical Holding Company Ltd. stock fall?

The decline in Biohaven Pharmaceutical Holding Company Ltd. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

$18.82

8.44% today

NYSE, Apr 04, 09:48 pm CET

ISIN

VGG111961055

Symbol

BHVN

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Biohaven Pharmaceutical Holding Company Ltd. Target price 2025 - Analyst rating & recommendation

Biohaven Pharmaceutical Holding Company Ltd. Classifications & Recommendation:

Buy

100%

Biohaven Pharmaceutical Holding Company Ltd. Price Target

Target Price	$62.20
Price	$20.55
Potential	202.68% register free of charge
Number of Estimates	15

	15 Analysts have issued a price target Biohaven Pharmaceutical Holding Company Ltd. 2026 . The average Biohaven Pharmaceutical Holding Company Ltd. target price is $62.20. This is 202.68% register free of charge higher than the current stock price. The highest price target is $76.00 269.83% register free of charge , the lowest is $54.00 162.77% register free of charge .
	A rating was issued by 16 analysts: 16 Analysts recommend Biohaven Pharmaceutical Holding Company Ltd. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Biohaven Pharmaceutical Holding Company Ltd. stock has an average upside potential 2026 of 202.68% register free of charge . Most analysts recommend the Biohaven Pharmaceutical Holding Company Ltd. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-9.28	-6.83
	61.95%	26.40%
P/E		negative
EV/Sales		80.78

16 Analysts have issued a Biohaven Pharmaceutical Holding Company Ltd. forecast for earnings per share. The average Biohaven Pharmaceutical Holding Company Ltd. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-9.28	61.95%
2025	$-6.83 26.40% Unlock
2026	$-5.83 14.64% Unlock
2027	$-4.40 24.53% Unlock
2028	$-2.38 45.91% Unlock
2029	$0.31 113.03% Unlock

Current	-2.19	77.31%
2025	-3.01 37.44% Unlock
2026	-3.53 17.28% Unlock
2027	-4.67 32.29% Unlock
2028	-8.62 84.58% Unlock
2029	66.41 870.42% Unlock

Biohaven Pharmaceutical Holding Company Ltd....

Current Biohaven Pharmaceutical Holding Company Ltd. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Morgan Stanley	Locked ➜ Locked	Locked	Mar 07 2025
JP Morgan	Locked ➜ Locked	Locked	Mar 05 2025
RBC Capital	Locked ➜ Locked	Locked	Mar 04 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 04 2025
Deutsche Bank	Locked ➜ Locked	Locked	Feb 11 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 17 2024
Cantor Fitzgerald	Locked ➜ Locked	Locked	Dec 17 2024

Analyst Rating	Date
Locked Morgan Stanley: Locked ➜ Locked	Mar 07 2025
Locked JP Morgan: Locked ➜ Locked	Mar 05 2025
Locked RBC Capital: Locked ➜ Locked	Mar 04 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 04 2025
Locked Deutsche Bank: Locked ➜ Locked	Feb 11 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 17 2024
Locked Cantor Fitzgerald: Locked ➜ Locked	Dec 17 2024

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now